Therapeutic angiogenesis: Time for the next phase

Journal of the American College of Cardiology

Volumn 36, Issue 4, 2000, Pages 1245-1247

  Pantely, George A ^a   Porter, John M ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EDITORIAL; HEART MUSCLE ISCHEMIA; HUMAN; NONHUMAN; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANIMALS; BLOOD FLOW VELOCITY; DRUG ADMINISTRATION ROUTES; ENDOTHELIAL GROWTH FACTORS; FIBROBLAST GROWTH FACTOR 2; HUMANS; ISCHEMIA; LYMPHOKINES; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEIN ISOFORMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033819809     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)00885-8     Document Type: Editorial

References (22)

1. Angiogenesis: Initiation and control
2. Angiogenesis by gene therapy: A new horizon for myocardial revascularization?
3. Angiogenic therapy of the human heart
4. Angiogenesis in ischemic heart disease
5. Delivery strategies to achieve therapeutic myocardial angiogenesis
6. The biology of vascular endothelial growth factor
7. Overview of the fibroblast growth factor and receptor families: Complexity, functional diversity and implications for future cardiovascular research
8. Basic fibroblast growth factor enhances myocardial collateral flow in a canine model
9. Vascular endothelial growth factor administration in chronic myocardial ischemia
10. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in rabbit model of acute lower limb ischemia: Dose-response effect of basic fibroblast growth factor
11. Enhanced revascularization of the ischemic limb by angiogenic therapy
12. Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia
13. Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model
14. 165 as sole therapy for myocardial ischemia
15. Angiogenic gene therapy. Phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease
16. Therapeutic angiogenesis with basic fibroblast growth factor: Technique and early results
17. Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion. Evidence for a dose-dependent effect
18. Induction of neoangiogenesis in ischemic myocardium by human growth factors. First clinical results of a new treatment of coronary heart disease
19. Double-blind, placebo controlled trial of recombinant human vascular endothelial growth factor: The VIVA trial
20. Constitutive expression of phVEGF165 after intramuscular gene transfer collateral vessel development in patients with critical limb ischemia
21. Basic fibroblast growth factor in patients with intermittent claudication. Results of a phase I trial
22. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities. A critical review